Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",16222,104,1.49 [1.24-1.78],2.2136848648179063e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,16271,105,1.92 [1.51-2.45],1.2951860121485458e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,16562,112,1.65 [1.29-2.10],6.235791289675969e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,16509,108,2.31 [1.65-3.23],1.131401487585115e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,14404,96,2.76 [1.63-4.69],0.0001689370044218
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,14479,98,3.97 [2.62-6.01],7.339398311372729e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,16395,104,2.30 [1.41-3.73],0.0008011357216215
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,14404,96,1.93 [1.42-2.62],3.030771457626869e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,16643,113,2.58 [1.50-4.45],0.0006315824582031
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,16718,111,2.53 [1.78-3.59],1.879487984699829e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,16497,109,1.65 [1.42-1.91],3.648139978224184e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,16643,113,2.33 [1.54-3.53],5.897272793556917e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,16562,112,1.57 [1.30-1.90],3.8057783473031615e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,14096,95,1.59 [1.28-1.97],2.511444143200292e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,14046,96,1.47 [1.19-1.83],0.000421630762879
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,16779,112,8.45 [4.01-17.80],1.9743597655303624e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,16588,110,1.66 [1.28-2.15],0.0001142718216017
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,14485,98,0.49 [0.37-0.65],8.437572213874132e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,16634,109,0.31 [0.18-0.53],3.082591377612891e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,16497,109,1.92 [1.37-2.69],0.0001387272338639
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,16222,104,1.68 [1.36-2.07],1.2842901963580115e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,16588,110,3.95 [2.35-6.65],2.2481065824928165e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,14181,95,3.24 [1.78-5.90],0.0001179501847066
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,16696,107,1.85 [1.48-2.31],5.471130380984133e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,16186,102,1.41 [1.16-1.71],0.000489184977265
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,16666,111,1.97 [1.45-2.68],1.536292764627974e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,14125,97,3.96 [2.26-6.93],1.4466199463745618e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",16271,105,1.36 [1.15-1.60],0.0003584211137893
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,16723,107,1.79 [1.32-2.43],0.0001634805557134
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,14109,95,1.75 [1.32-2.31],9.143317389497564e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,16666,111,2.17 [1.53-3.08],1.5635620768138823e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,16497,109,2.64 [1.68-4.14],2.58513734804804e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,16618,113,3.11 [1.85-5.23],1.9646879821979904e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,14181,95,1.96 [1.33-2.91],0.0007580189516306
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,16696,107,2.25 [1.44-3.52],0.0003909936452381
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,14466,98,3.73 [2.41-5.76],3.0090336570584796e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,16424,105,1.65 [1.25-2.20],0.0005098255689244
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,16562,112,2.40 [1.54-3.75],0.0001220705038451
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,16562,112,2.41 [1.69-3.44],1.2806527879478898e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,16497,109,1.61 [1.25-2.08],0.0002335509176576
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,16610,112,5.56 [2.79-11.09],1.0631725861017536e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,16627,110,1.39 [1.16-1.66],0.0003050367759435
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,14288,97,0.53 [0.40-0.70],7.55604964793747e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",14454,97,2.14 [1.60-2.86],2.6578924843976375e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,16263,106,1.42 [1.19-1.71],0.0001473663101827
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,16675,108,2.31 [1.48-3.61],0.0002363263985022
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,16739,109,2.42 [1.76-3.31],4.191576755516194e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,16666,111,0.55 [0.41-0.74],8.91852102641357e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,16536,110,1.89 [1.32-2.71],0.0004785649596132
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,16562,112,2.74 [1.95-3.87],7.789154286305313e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,14181,95,2.62 [1.77-3.87],1.5123800023182265e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",14109,95,1.70 [1.28-2.25],0.000213723382836
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,16643,113,4.44 [2.09-9.45],0.000109237937359
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,16643,113,2.74 [1.57-4.80],0.0004179564250687
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,14485,98,2.13 [1.39-3.27],0.000527187659319
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,15532,104,2.29 [1.78-2.95],1.6628223757709926e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,16739,109,2.43 [1.51-3.91],0.0002448417121116
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,16621,111,2.50 [1.53-4.10],0.0002699140123132
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,16536,110,1.75 [1.32-2.32],9.248948324346413e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,16479,107,1.50 [1.28-1.75],3.329689484902116e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,16696,107,3.90 [2.03-7.47],4.1447869201083e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,16536,110,2.72 [1.96-3.78],2.1669884100860284e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,16411,110,2.17 [1.45-3.25],0.0001574094512307
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,14387,95,2.10 [1.44-3.06],0.0001073702878634
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,16723,107,2.37 [1.62-3.45],7.724790357234023e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,16395,104,2.28 [1.42-3.67],0.00067711480333
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,16779,112,4.83 [2.20-10.58],8.323135662772939e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,16779,112,4.03 [2.38-6.82],2.095286958764961e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,16012,107,1.47 [1.20-1.80],0.0001979841687178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,15996,106,2.12 [1.44-3.13],0.0001285323990978
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,16694,107,2.52 [1.53-4.15],0.0002944156398473
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,14466,98,1.61 [1.26-2.07],0.0001796099132863
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,16525,109,0.48 [0.34-0.67],1.5475224843168654e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,16637,112,0.40 [0.25-0.65],0.0002055270201705
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,16637,112,7.21 [3.85-13.50],6.657540166425765e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,16585,112,1.14 [1.06-1.22],0.0004603614471555
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,16536,113,3.34 [2.20-5.07],1.6169806805797752e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,16696,107,1.90 [1.34-2.68],0.0002863090165966
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,13846,91,1.61 [1.21-2.12],0.0009298154684217
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,16779,112,2.38 [1.83-3.09],7.837844071135272e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,16567,110,2.25 [1.77-2.88],7.206992729100067e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",14479,98,1.89 [1.40-2.55],3.248533875493808e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,14417,95,1.85 [1.49-2.29],3.1430121300544475e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,16511,110,3.87 [2.06-7.27],2.56477295034713e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",16497,109,1.85 [1.49-2.29],3.0641777268357305e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,16723,107,1.35 [1.19-1.52],2.65696328331034e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,16695,107,1.73 [1.37-2.18],4.6805444710040695e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,16588,110,2.69 [1.80-4.04],1.6669039843387578e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,16739,109,3.40 [2.31-5.00],5.385077330388665e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,14418,97,1.85 [1.46-2.34],3.697590957321655e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,16530,108,2.90 [1.79-4.69],1.4645233450430368e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,14039,96,2.09 [1.36-3.21],0.0007402639936485
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,16643,113,2.92 [1.56-5.48],0.0008526290380514
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,16666,111,0.38 [0.27-0.53],1.3170048647233754e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,16779,112,3.14 [2.46-4.02],5.2685281820886096e-20
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,16562,112,2.86 [1.93-4.25],1.961725480384338e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,16497,109,3.47 [2.42-4.98],1.6524427617347414e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,16562,112,2.18 [1.41-3.35],0.0004099592041064
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,16643,113,2.35 [1.61-3.43],1.0456103936971691e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,16666,111,2.92 [1.89-4.49],1.1701999718494909e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,16739,109,2.32 [1.43-3.76],0.000686083679136
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,16567,110,4.72 [2.62-8.50],2.2543944525525066e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,16740,111,1.89 [1.30-2.74],0.0008655276818171
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,16536,110,1.84 [1.37-2.47],4.290703781338088e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,16536,110,2.08 [1.40-3.09],0.0002665912430254
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,14417,95,1.82 [1.37-2.42],4.167048410788474e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,16588,110,3.99 [2.18-7.31],7.180032729086301e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,16489,108,2.89 [1.67-5.00],0.0001428820689478
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,14479,98,3.53 [2.58-4.82],3.0056022887524032e-15
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,14192,96,1.80 [1.34-2.42],0.0001019641036964
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",16497,109,1.51 [1.28-1.78],1.5905838244261286e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",14023,89,1.48 [1.30-1.67],1.564114473514331e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,16666,111,1.61 [1.22-2.13],0.000799856216809
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,16564,113,1.67 [1.28-2.17],0.0001280254529089
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,16579,112,2.41 [1.47-3.94],0.0004649260222538
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,16718,111,2.83 [1.68-4.77],9.65133529587084e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,16779,112,3.32 [2.10-5.26],2.931032404197075e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,16508,112,2.62 [1.61-4.27],0.0001121771621048
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,14181,95,0.32 [0.18-0.58],0.0001947048605133
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,16497,109,1.68 [1.39-2.02],4.708047274998001e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,16245,105,2.16 [1.51-3.10],2.65029171424838e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,16696,107,2.42 [1.70-3.45],1.0141449484927216e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,14209,95,1.57 [1.20-2.04],0.0008947843600141
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,16186,102,1.83 [1.37-2.44],3.642771292012631e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,14404,96,3.20 [2.01-5.09],9.206901635291e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,16739,109,4.43 [2.64-7.42],1.5347275045354687e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,16779,112,2.28 [1.40-3.70],0.0008999468746159
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,16689,111,3.45 [2.12-5.62],6.21624610189302e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,16637,112,1.81 [1.42-2.31],1.4675903962415205e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,14444,95,2.14 [1.54-2.97],5.577036731858437e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,14454,97,2.24 [1.53-3.27],3.406124906396482e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,16562,112,2.73 [1.85-4.03],4.897060724255928e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,16562,112,2.84 [1.68-4.80],0.0001030650876262
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,14046,96,1.97 [1.42-2.74],5.3209649780267554e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,16739,109,2.97 [1.81-4.87],1.6419713579694845e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,16374,108,2.98 [1.97-4.51],2.408677915828379e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,14466,98,3.40 [1.65-6.99],0.0008984383499681
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,16637,112,3.65 [2.12-6.28],2.863193553088825e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,16588,110,1.90 [1.40-2.57],3.268450694478849e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,16472,112,2.87 [1.67-4.93],0.000133455644924
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,16710,110,4.25 [2.41-7.51],5.755793067955339e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,14046,96,1.68 [1.24-2.28],0.000898453280768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,16693,111,2.54 [1.81-3.55],5.488889494053033e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,16634,109,0.39 [0.24-0.63],0.0001559374575175
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,16723,107,3.03 [1.58-5.79],0.000839400952597
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,16476,108,2.18 [1.42-3.36],0.0003880689470411
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,16714,112,2.30 [1.42-3.73],0.0007122081034807
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,16592,113,3.78 [2.37-6.02],2.255053787920382e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,16696,107,3.01 [1.79-5.04],2.9208888638325467e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,16665,107,1.77 [1.27-2.46],0.000714039939647
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,16562,112,2.33 [1.66-3.28],1.072352187539008e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,14404,96,1.46 [1.17-1.81],0.0006351249719482
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,16779,112,1.93 [1.39-2.67],8.093401141213523e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,16740,111,3.35 [2.34-4.81],5.099129279959346e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,16410,109,1.48 [1.19-1.84],0.0004483222422393
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,16497,109,3.08 [1.89-5.04],6.960374609012377e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,16536,110,2.31 [1.47-3.63],0.0002842151181251
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,16562,112,2.51 [1.45-4.32],0.0009686675201008
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,16588,110,1.76 [1.26-2.46],0.0009174395802593
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,16545,110,5.77 [3.65-9.14],6.922084451922607e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,16592,113,2.64 [1.69-4.13],2.072330661399164e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,16493,110,2.86 [1.85-4.44],2.5560874105280944e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,16757,112,1.90 [1.34-2.69],0.0003318534608164
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,14466,98,3.62 [2.30-5.71],3.0578289722216e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,16696,107,1.85 [1.32-2.58],0.0003473240109723
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,16536,110,1.58 [1.28-1.95],2.1283092128247582e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",14444,95,1.57 [1.22-2.03],0.0004884114110876
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,14702,92,2.64 [1.81-3.85],4.95146799953774e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,16714,109,1.86 [1.29-2.67],0.0008384612502037
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,16508,108,3.49 [2.01-6.07],9.121053479957546e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,16588,110,3.42 [2.64-4.44],1.8384010731199042e-20
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,16666,111,2.00 [1.39-2.86],0.0001601005520655
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,16434,110,4.22 [2.99-5.95],2.8751083758093714e-16
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,16739,109,2.12 [1.47-3.06],5.615790455481407e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,16564,113,4.03 [2.46-6.59],2.8690280740996483e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,16592,113,1.97 [1.38-2.82],0.0001809971452905
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,16588,110,2.51 [1.60-3.95],6.803659418798645e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,16588,110,1.61 [1.24-2.10],0.0004392568894334
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,16696,107,2.90 [1.66-5.06],0.0001780773386651
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,16424,105,1.54 [1.20-1.99],0.0007692685013907
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,16536,110,0.61 [0.46-0.81],0.0005680321029768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,14479,98,2.32 [1.51-3.58],0.0001398684526599
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,16456,113,1.66 [1.23-2.23],0.0008571452846898
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,14404,96,1.45 [1.21-1.75],8.628626581628782e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,16424,105,2.13 [1.44-3.16],0.0001637878760035
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,16634,109,3.51 [2.14-5.77],6.921858562928611e-07
